This led to an upregulation of 1A transcription and a decrease in Gsα mRNA levels in the kidney, which consequently resulted in hypocalcemia, hyperphosphatemia, and secondary hyperparathyroidism (85, 144). This evidence concerns the gene GNAS and hyperphosphatemia.